세계의 지노타이핑 시장 - 산업규모, 점유율, 동향, 기회, 예측, 제품별, 기술별, 용도별, 최종 용도별, 지역별 부문, 지역별, 경쟁(2020-2030년)
Genotyping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End Use, By Region & Competition, 2020-2030F
상품코드:1691712
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
지노타이핑 세계 시장 규모는 2024년에 162억 5,000만 달러로 평가되었으며, 예측 기간 중 CAGR은 8.74%를 나타낼 전망이며, 2030년에는 268억 7,000만 달러에 달할 것으로 예측되고 있습니다.
세계 지노타이핑 시장은 생명공학과 생명과학 분야에서 역동적이고 빠르게 성장하는 분야입니다. 지노타이핑은 DNA 서열의 돌연변이를 포함하는 개인의 유전자 구성을 결정하는 과정입니다. 이 정보는 맞춤형 의료 및 질병 연구에서 농업 및 가계 검사에 이르기까지 광범위한 응용 분야에서 매우 중요합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
162억 5,000만 달러
시장 규모 : 2030년
268억 7,000만 달러
CAGR : 2025-2030년
8.74%
급성장 부문
시약 및 키트
최대 시장
북미
지노타이핑 시장은 특히 유전체 연구에 대한 정부기관으로부터의 자금 제공 증가나 연구의 신속화를 목적으로 하는 제약기업이나 생명공학기업으로부터의 기여에 의해 성장이 전망되고 있습니다. 2018년 9월 미국 국립위생연구소(NIH)가 2018년 9월 정밀의료연구에 특화된 미국 전역의 3개 유전체센터 설립을 위한 'All of Us Research Program'에 2,860만 달러를 공여한 것을 들 수 있습니다.
암과 유전성 질환을 포함한 만성 질환의 세계 증가는 유전자형에 기반한 진단 검사 수요를 촉진하는 것으로 보입니다. 예를 들면, 세계보건기구(WHO)는 2020년에 세계에서 1,910만명이 새롭게 암으로 진단된다고 보고하고 있습니다. 또한 인유두종 바이러스(HPV)나 B형 간염 바이러스(HBV)/C형 간염 바이러스(HCV)와 같은 암을 일으키는 바이러스는 세계 규모에서 암 관련 사망의 약 20%를 일으키고 있습니다. 암 환자 수는 인구 증가와 고령화로 향후 20년간 약 70% 증가할 것으로 예측됩니다. 따라서 암의 유병률 증가는 이 시장의 중요한 원동력이 될 것으로 예상됩니다.
주요 시장 성장 촉진요인
제노 타이핑 기술의 진보
주요 시장 과제
데이터 관리 및 해석
주요 시장 동향
멀티오믹스 접근의 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 지노타이핑 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품별(기기, 시약 및 키트, 소프트웨어, 서비스)
기술별(PCR, 모세관 전기영동, 마이크로어레이, 시퀀싱, 질량 분석, 기타)
용도별(약리 유전체학, 진단 및 맞춤형 의료, 농업 바이오테크놀러지, 동물 유전학, 기타)
최종 용도별(제약 및 바이오 의약품 기업, 진단 및 조사 기관, 학술 기관, 기타)
지역별
기업별(2024)
제품 시장 맵
제품별
기술별
용도별
최종 용도별
지역별
제6장 북미의 지노타이핑 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 지노타이핑 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
영국
프랑스
이탈리아
스페인
제8장 아시아태평양의 지노타이핑 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
일본
인도
호주
한국
제9장 남미의 지노타이핑 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 지노타이핑 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카: 국가별 분석
사우디아라비아
아랍에미리트(UAE)
쿠웨이트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
합병과 인수
제품 출시
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Thermo Fisher Scientific Inc.
Illumina Inc.
QIAGEN NV
F Hoffmann-La Roche AG
Danaher Corporation
Agilent Technologies, Inc.
Eurofins Scientific Inc.
GE HealthCare
Bio-Rad Laboratories Inc.
Standard BioTools(TM)
제15장 전략적 제안
제16장 기업 소개와 면책사항
SHW
영문 목차
영문목차
Global Genotyping Market was valued at USD 16.25 billion in 2024 and is expected to reach USD 26.87 billion by 2030 with a CAGR of 8.74% during the forecast period. The global genotyping market is a dynamic and rapidly growing sector within the field of biotechnology and life sciences. Genotyping is the process of determining an individual's genetic makeup, including variations in their DNA sequence. This information is crucial for a wide range of applications, from personalized medicine and disease research to agriculture and ancestry testing.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 16.25 Billion
Market Size 2030
USD 26.87 Billion
CAGR 2025-2030
8.74%
Fastest Growing Segment
Reagents & Kits
Largest Market
North America
The genotyping market is expected to experience growth driven by increased government funding, particularly for genomic research from governmental bodies, as well as contributions from pharmaceutical and biotechnology companies, aimed at expediting research. A noteworthy example of this is the National Institutes of Health (NIH) granting USD 28.6 million in September 2018 to the "All of Us Research Program" for establishing three genome centers across the United States dedicated to precision medicine research.
The global rise in chronic diseases, including cancer and genetic disorders, is set to fuel the demand for genotypic-based diagnostic testing. To illustrate, the World Health Organization (WHO) reported 19.1 million new cancer cases diagnosed worldwide in 2020. Moreover, cancer-causing viruses like Human Papilloma Virus (HPV) and Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) are responsible for approximately 20% of cancer-related deaths on a global scale. The number of cancer cases is projected to increase by roughly 70% over the next two decades, driven by population growth and aging. Therefore, the increasing prevalence of cancer is expected to be a significant driving force for this market.
Key Market Drivers
Advancements in Genotyping Technologies
Genotyping, the process of analyzing an individual's genetic makeup, is undergoing a revolution thanks to advancements in genotyping technologies. These innovations have not only enhanced the efficiency and accuracy of genotyping but also expanded its applications across various sectors, including healthcare, research, agriculture, and personalized medicine. One of the most significant factors propelling the genotyping market forward is the advent of high-throughput genotyping platforms. These platforms can analyze thousands or even millions of genetic markers in a single experiment, significantly increasing the speed and cost-effectiveness of genotyping. Researchers and clinicians can process larger datasets quickly, making genotyping accessible for a wide range of applications.
Next-generation sequencing, or NGS, is a game-changer in genotyping. It allows for the simultaneous sequencing of a person's entire genome, making it possible to identify even the rarest genetic variations. NGS is not only faster and more affordable than traditional Sanger sequencing, but it also generates vast amounts of data, enabling comprehensive genomic analysis. This technology has become essential in research, clinical diagnostics, and personalized medicine. Advancements in genotyping technologies have significantly improved the accuracy and resolution of genotyping results. Single nucleotide polymorphism (SNP) genotyping, for example, has become highly accurate, making it an invaluable tool in identifying genetic markers associated with diseases, drug responses, and other traits. This precision has bolstered the credibility of genotyping in both research and clinical applications.
Key Market Challenges
Data Management and Interpretation
One of the primary challenges in the genotyping market is the management and interpretation of the massive amounts of genetic data generated. Genotyping technologies, especially high-throughput platforms and next-generation sequencing, produce enormous datasets. The efficient analysis and interpretation of this data requires robust bioinformatics tools and skilled personnel, making data management a significant hurdle.
Key Market Trends
Integration of Multi-Omics Approaches
Genotyping is increasingly being integrated with other omics technologies such as proteomics and metabolomics. This holistic approach allows researchers to gain a more comprehensive understanding of biological systems. By analyzing genetic, protein, and metabolic data together, researchers can uncover intricate relationships and potential biomarkers for various diseases and conditions.
Key Market Players
Thermo Fisher Scientific Inc.
Illumina Inc.
QIAGEN N.V.
F Hoffmann-La Roche AG
Danaher Corporation
Agilent Technologies, Inc.
Eurofins Scientific Inc.
GE HealthCare
Bio-Rad Laboratories Inc.
Standard BioTools(TM)
Report Scope:
In this report, the Global Genotyping Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Genotyping Market, By Product:
Instruments
Reagents & Kits
Software and Services
Genotyping Market, By Technology:
PCR
Capillary Electrophoresis
Microarrays
Sequencing
Mass Spectrometry
Others
Genotyping Market, By Application:
Pharmacogenomics
Diagnostics and Personalized Medicine
Agricultural Biotechnology
Animal Genetics
Others
Genotyping Market, By End Use:
Pharmaceutical and Biopharmaceutical Companies
Diagnostics and Research Laboratories
Academic Institutes
Others
Genotyping Market, By Region:
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Genotyping Market.
Available Customizations:
Global Genotyping market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Genotyping Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
5.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
5.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
5.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Technology
5.3.3. By Application
5.3.4. By End Use
5.3.5. By Region
6. North America Genotyping Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
6.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
6.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
6.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Genotyping Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Technology
6.3.1.2.3. By Application
6.3.1.2.4. By End Use
6.3.2. Canada Genotyping Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Technology
6.3.2.2.3. By Application
6.3.2.2.4. By End Use
6.3.3. Mexico Genotyping Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Technology
6.3.3.2.3. By Application
6.3.3.2.4. By End Use
7. Europe Genotyping Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
7.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
7.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
7.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Genotyping Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Technology
7.3.1.2.3. By Application
7.3.1.2.4. By End Use
7.3.2. United Kingdom Genotyping Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Technology
7.3.2.2.3. By Application
7.3.2.2.4. By End Use
7.3.3. France Genotyping Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Technology
7.3.3.2.3. By Application
7.3.3.2.4. By End Use
7.3.4. Italy Genotyping Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Technology
7.3.4.2.3. By Application
7.3.4.2.4. By End Use
7.3.5. Spain Genotyping Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Technology
7.3.5.2.3. By Application
7.3.5.2.4. By End Use
8. Asia-Pacific Genotyping Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
8.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
8.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
8.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Genotyping Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Technology
8.3.1.2.3. By Application
8.3.1.2.4. By End Use
8.3.2. Japan Genotyping Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Technology
8.3.2.2.3. By Application
8.3.2.2.4. By End Use
8.3.3. India Genotyping Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Technology
8.3.3.2.3. By Application
8.3.3.2.4. By End Use
8.3.4. Australia Genotyping Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Technology
8.3.4.2.3. By Application
8.3.4.2.4. By End Use
8.3.5. South Korea Genotyping Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Technology
8.3.5.2.3. By Application
8.3.5.2.4. By End Use
9. South America Genotyping Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
9.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
9.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
9.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Genotyping Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Technology
9.3.1.2.3. By Application
9.3.1.2.4. By End Use
9.3.2. Argentina Genotyping Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Technology
9.3.2.2.3. By Application
9.3.2.2.4. By End Use
9.3.3. Colombia Genotyping Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Technology
9.3.3.2.3. By Application
9.3.3.2.4. By End Use
10. Middle East and Africa Genotyping Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Instruments, Reagents & Kits, Software and Services)
10.2.2. By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others)
10.2.3. By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others)
10.2.4. By End Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others)
